Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

CJC-1295 (without DAC) and TB-500 (Ac-LKKTETQ) Interaction: Synergistic | Peptide Database

Can you take CJC-1295 (without DAC) with TB-500 (Ac-LKKTETQ)? Synergistic interaction (47% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

TB-500 (Ac-LKKTETQ)

Thymosin Beta-4 Active Fragment | Healing Peptide

TB-500 contains the LKKTETQ sequence which is the actin-binding motif of full-length thymosin beta-4. This fragment shares many properties of the parent protein regarding cell proliferation, differentiation, and migration.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with TB-500 (Ac-LKKTETQ)?

Yes, CJC-1295 (without DAC) and TB-500 (Ac-LKKTETQ) can generally be taken together. CJC-1295 (without DAC) and TB-500 (Ac-LKKTETQ) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is CJC-1295 (without DAC) and TB-500 (Ac-LKKTETQ) safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and TB-500 (Ac-LKKTETQ)?

CJC-1295 (without DAC) and TB-500 (Ac-LKKTETQ) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 (without DAC) and TB-500 (Ac-LKKTETQ)?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and TB-500 (Ac-LKKTETQ) has a half-life of Not precisely established; effects persist longer than 24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question